Biocure Technology (XCNQ:CURE) Ending Cash Position : C$0.02 Mil (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biocure Technology Ending Cash Position?

Biocure Technology's Ending Cash Position for the quarter that ended in Dec. 2024 was C$0.02 Mil.

Biocure Technology's quarterly Ending Cash Position declined from Jun. 2024 (C$0.03 Mil) to Sep. 2024 (C$0.03 Mil) and declined from Sep. 2024 (C$0.03 Mil) to Dec. 2024 (C$0.02 Mil).

Biocure Technology's annual Ending Cash Position declined from Dec. 2022 (C$0.04 Mil) to Dec. 2023 (C$0.00 Mil) but then increased from Dec. 2023 (C$0.00 Mil) to Dec. 2024 (C$0.02 Mil).

Biocure Technology Ending Cash Position Historical Data

The historical data trend for Biocure Technology's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocure Technology Ending Cash Position Chart

Biocure Technology Annual Data

Trend

Mar15

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

0.05

0.16

0.04

0.02

Biocure Technology Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															-	-	0.03	0.03	0.02

Biocure Technology Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biocure Technology's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.004	+	0.014
	=	0.02

Biocure Technology's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.027	+	-0.009
	=	0.02

Biocure Technology Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Biocure Technology's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocure Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocure Technology Inc (XCNQ:CURE) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

BICTF:USA 1WH0:Germany

Address

1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9

Website

https://www.biocuretech.com

Biocure Technology Inc is a South Korean-based Bio-Pharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It Developing Biosimilars and CAR-T Cell pharmaceuticals. Its products are CAR-T Cell Therapy, Interferon Beta, Ranibizumab, and PEG-Filgrastim.

Executives

Konstantin Lichtenwald

Director, Senior Officer